DONOVAN MATHERNE: Open Payments
NPI 1285936542 · BATON ROUGE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$632 in 32 payments from 11 companies in 2025. Trend: 2023 $617 · 2024 $720 · 2025 $632
Food & beverage: $632
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 9 | $198 |
| PFIZER INC. | 5 | $95 |
| Collegium Pharmaceutical, Inc. | 4 | $80 |
| Axsome Therapeutics, Inc. | 3 | $60 |
| ABBVIE INC. | 3 | $47 |
| Valinor Pharma, LLC | 2 | $39 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $34 |
| Averitas Pharma Inc. | 1 | $27 |
| Abbott Laboratories | 1 | $23 |
| Azurity Pharmaceuticals, Inc. | 1 | $15 |
Products named: NURTEC ODT, Belbuca, Intracept, Symbravo, General - Pain Management, WaveWriter Alpha Prime 16, MOVANTIK, RELISTOR.
Industry payments across LA — which companies pay providers there.
